Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2023-05-12 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
112年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the year 112 (Taiwan calendar, corresponding to 2023). It includes detailed financial data such as revenue, costs, expenses, net profit, and earnings per share for the quarter ending March 31, 2023, compared to the same period in the previous year. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2274 characters, which is sufficient to contain financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-05-12 Chinese
112年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple dates within a fiscal year, including assets, liabilities, and equity. The presence of actual financial figures and the nature of the data indicate this is a financial report rather than an announcement or certification. The document length is 3889 characters, which is relatively short but contains substantive financial data. The data corresponds to a quarterly period (first quarter of year 112 in the Taiwanese calendar, which corresponds to 2023). Therefore, this document is best classified as an Interim / Quarterly Report (IR).
2023-05-12 Chinese
112年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 杏輝, providing information on loan balances and endorsement guarantees for the current and previous months. It contains tabulated financial data but is very short (624 characters) and does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or compliance update rather than a full financial report or announcement of a meeting or vote. There is no indication of an annual or interim report, audit report, earnings release, or other specific filings. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other categories.
2023-05-10 Chinese
112年4月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or audit information. The length is short (771 characters), and it is a straightforward financial summary rather than a full report or announcement. It does not fit the criteria for Annual Report, Interim Report, Earnings Release, or other detailed filings. It is a brief financial summary, consistent with a Fund Information / Factsheet (FS) type document, which typically provides key financial facts and figures in a concise format.
2023-05-10 Chinese
112年04月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, chairpersons, general managers, and their family members. It lists the number of shares held, changes in holdings, and related information. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a proxy statement or voting result announcement. It is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is substantial and contains actual data, not just an announcement or certification, so it is not RNS or RPA.
2023-05-08 Chinese
112年04月董事會成員及持股
Major Shareholding Notification Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, pledged shares, and related parties' holdings. It is a disclosure of insider shareholdings and changes, typical of a Director's Dealing or insider shareholding notification. There is no indication of financial results, audit information, or meeting materials. The document length is 3432 characters, which is relatively short but contains detailed insider shareholding data. This matches the definition of Major Shareholding Notification (MRQ) rather than a general regulatory filing or other categories. Therefore, the document is best classified as Major Shareholding Notification (MRQ).
2023-05-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.